失代偿期肝硬化与慢加急性肝衰竭的混合纤溶表型:合并并发症及生存不良者呈低纤溶
研究评估急性失代偿期肝硬化(AD,n=52)或慢加急性肝衰竭(ACLF,n=57)患者的血浆纤溶潜力,并与40名健康志愿者比较。AD患者中位凝块溶解时间(CLT)较健康对照缩短,ACLF患者与对照相当,但患者CLT变异性远大于健康对照。CLT延长与脓毒症、任何器官衰竭及30天内死亡相关。
要点
- 急性失代偿期肝硬化患者中位CLT较健康志愿者缩短,ACLF患者与对照相当。
- 患者CLT变异性远大于健康对照,部分患者CLT明显延长或缩短。
- CLT延长与脓毒症、任何器官衰竭及30天内死亡相关。
核心结论
- 急性重症肝硬化患者呈现混合纤溶表型,基线低纤溶与脓毒症、器官衰竭和短期死亡相关。
研究设计与样本
- 研究纳入急性失代偿期肝硬化患者52例和慢加急性肝衰竭患者57例,并与40名健康志愿者比较,评估血浆纤溶潜力。
主要发现
- 与40名健康志愿者相比,AD患者中位CLT缩短,ACLF患者中位CLT与对照相当。
- 患者CLT变异性远大于健康对照,两组患者中均有部分患者CLT明显延长或缩短。
- CLT与脓毒症及任何器官衰竭(按欧洲慢性肝衰竭研究基金会器官衰竭评分定义)相关,上述患者CLT更长。
- 随访期间发生出血或血栓事件的患者与未发生者CLT无差异。
- 入院后30天内死亡的患者基线CLT显著更长。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Patients with liver disease acquire complex changes in their hemostatic system, which results in a fragile rebalanced status. The status of the fibrinolytic system is controversial, as is the role of fibrinolytic dysfunction in bleeding and thrombosis in patients with cirrhosis. Here, we aimed to determine fibrinolytic status and its relationship with outcome in acutely ill patients with cirrhosis. APPROACH AND RESULTS: We assessed plasma fibrinolytic potential in a large cohort of patients with acutely decompensated cirrhosis (AD, n = 52) or acute-on-chronic liver failure (ACLF, n = 57). Compared with 40 healthy volunteers, median clot lysis times (CLTs) were shorter in patients with AD but comparable to controls in patients with ACLF. However, the variability in CLTs in patients was much larger than in healthy controls, and in both patient groups, a proportion of patients had clearly prolonged or shortened CLTs. The variability in CLTs in patients was not readily explained by variations in plasma levels of key fibrinolytic proteins. However, CLTs were clearly related to clinical characteristics, with longer CLTs in patients with sepsis and patients with any organ failure (as defined by the European Foundation for the Study of Chronic Liver Disease organ failure scores). CLTs were not different between patients that did or did not experience bleeding or a thrombotic event during follow-up. Baseline CLTs were substantially longer in patients that died within 30 days of admission. CONCLUSIONS: Our study demonstrates a mixed fibrinolytic phenotype in acutely ill patients with cirrhosis with baseline hypofibrinolysis associated with sepsis, organ failure, and short-term mortality. These associations may be explained by defective clearance of intraorgan microthrombi that have been proposed to drive organ failure.
引用
- Blasi A, Patel VC, Adelmeijer J, et al. Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute-on-Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival. Hepatology. 2019. PMID: 31465557. doi:10.1002/hep.30915
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。